Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells

Epidemiological studies indicate that metformin, a widely used type 2 diabetes drug, might reduce breast cancer risk and mortality in patients with type 2 diabetes. Metformin might protect against breast cancer indirectly by ameliorating systemic glucose homeostasis. Alternatively, it might target b...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajh, Maruša, Dolinar, Klemen, Miš, Katarina, Pavlin, Mojca, Pirkmajer, Sergej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852933/
https://www.ncbi.nlm.nih.gov/pubmed/27135408
http://dx.doi.org/10.1371/journal.pone.0154747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852933/
https://www.ncbi.nlm.nih.gov/pubmed/27135408
http://dx.doi.org/10.1371/journal.pone.0154747

Ejemplares similares